Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

IPC Elects New Board Member

Announcement introducing IPC Councilors’ newly elected board member, Curdin Conrad, MD, from the University Hospital of Lausanne, Switzerland, with his professional photo on a graphic background.

The International Psoriasis Council (IPC) is governed by a volunteer Board of Directors composed of leading experts in psoriasis, who provide strategic and professional guidance to the organization. We are pleased to announce that one new key opinion leader has been elected to join our Board, Dr. Curdin Conrad.

Dr. Conrad is Professor of Dermatology and Head of the Polyclinic and Center for Psoriasis at Lausanne University Hospital, Switzerland. He brings to the IPC Board a strong focus on inflammatory skin diseases, innate and adaptive immunity, and targeted immunotherapies, spanning basic science, translational research, and clinical care. An active educator in evidence-based clinical and investigative dermatology and immunology, Dr. Conrad will be a valuable addition to the IPC Board of Directors.

Meet Our Newest Board Member:

Curdin Conrad, MD

University Hospital of Lausanne

Lausanne, Switzerland

IPC Board Member

Bio

A complete list of our Board of Directors with their full biographies can be found here.

Categories

Recent Posts

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

VIEW

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

VIEW

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026